Why Do Men with PE Stop Taking Dapoxetine?
CCH Treatment Might Help Men with Peyronie's and Their Partners
Dapoxetine has a high discontinuation rate among men with premature ejaculation (PE), scientists report.
In a recent study of 182 men in South Korea, almost 80% stopped using dapoxetine within six months. By the end of the two-year follow-up period, the discontinuation rate was 90%.
The drug, a selective serotonin reuptake inhibitor (SSRI), is the only oral medication developed to treat PE.
The most common reason for stopping the drug was cost. Many men were also disappointed that PE was not curable and that dapoxetine had to be taken before intercourse.
For more details on the study, along with other reasons for discontinuation and the authors' suggestions for physicians, please click here.
Please note that a new research summary has been posted to the ISSM website.
"Changes in the Effects of Peyronie's Disease After Treatment With Collagenase Clostridium histolyticum [CCH]: Male Patients and Their Female Partners" by Irwin Goldstein, MD, et al. was published online in April in Sexual Medicine.
The study discusses the safety and efficacy of CCH in men and the perspectives of their female partners.
Please click here to see the summary.